Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth

Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth

Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown to possess anti-inflammation, anti-virus, and antitumor properties. However, whether ivermectin affects CRC is still unclear. The objective of this s...

Full description

Bibliographic Details
Main Authors: Shican Zhou, Hang Wu, Wenjuan Ning, Xiao Wu, Xiaoxiao Xu, Yuanqiao Ma, Xingwang Li, Junhong Hu, Chenyu Wang, Junpeng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
ivermectin
colorectal cancer
oxidative stress
apoptosis
cell cycle
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.717529/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.717529/full

Similar Items